Monday, 4 April 2011

Malignant Peritoneal Mesothelioma, Mesothelioma Awareness

Alessio Bridda, Clinica Chirurgica I, Department of Surgical and Gastroenterological Sciences, University of Padua, School of Medicine, Via Giustiniani 2, Policlinico III Piano, 35128 Padova, Italy;
Contributor Information.Mesothelioma
Disclosure: Alessio Bridda, MD, has disclosed no relevant financial relationships.
Disclosure: Ilaria Padoan, MD, has disclosed no relevant financial relationships.
Disclosure: Roberto Mencarelli, MD, has disclosed no relevant financial relationships.
Disclosure: Mauro Fresno, MD has disclosed no relevant financial relationships.
Small right arrow pointing to: This article has been cited by other articles in PMC.


Malignant peritoneal mesothelioma (MPM) is a rare aggressive tumor of the peritoneum, regarded as a universally fatal disease. It is poorly described and the knowledge of its natural history is very limited. Occupational and environmental asbestos exposure still remains a public health problem around the world. The incidence has increased in the past 2 decades. Only 20% to 33% of all mesotheliomas arise from the peritoneum itself; the pleura is the most common site of origin.

    
Mesotheliomas are aggressive tumors arising from serous surfaces: pleura (65%-70%), peritoneum (30%), tunica vaginalis testis, and pericardium (1%-2%).[1] Peritoneal mesothelioma was first described in 1908 by Miller and Wynn.

No comments:

Post a Comment